E. Morgan Flatley
On that date, the Board filled the additional Board seat by electing E. Morgan Flatley to serve as a member of the Board effective immediately.
Highest-materiality recent filing
Constellation Brands FY2026 comparable EPS $11.82, down 14%; withdraws FY2028 outlook
FY2026 net sales $9.139B, down 4% comparable; comparable EPS $11.82, down 14% YoY.
Constellation Brands appoints Nicholas Fink as President and CEO, effective April 13, 2026
Nicholas Fink, currently CEO of Fortune Brands Innovations (FBIN), will succeed Bill Newlands as President and CEO.
Constellation Brands Q3 FY2026: comparable EPS $3.06, net sales down 10% to $2.22B; $220M buyback
Q3 comparable EPS $3.06, reported EPS $2.88; net sales $2,223M (-10% YoY).
Constellation Brands Q2 comparable EPS $3.63 (-16% YoY); net sales $2.48B (-15%)
Comparable net sales $2.48B, organic decline 8%; comparable EBIT $886M (-13% YoY).
Constellation Brands slashes FY2026 EPS guidance; beer sales seen declining
Reported EPS guidance cut to $10.77-$11.07 from $12.07-$12.37; comparable EPS to $11.30-$11.60 from $12.60-$12.90.
Constellation Brands Q1 FY2026 comparable EPS $3.22, down 10% YoY; net sales down 6%
Reported net sales $2,515M (-6% YoY); comparable net sales also $2,515M.
Constellation Brands closes wine divestiture to The Wine Group; redeems $900M senior notes
Sold mainstream wine brands (Woodbridge, Meiomi, etc.) to The Wine Group; retained higher-end portfolio priced $15+.
Constellation Brands reports FY25 earnings beat, divests mainstream wine brands, $4B buyback
FY25 comparable EPS $13.78 (up 11% YoY), net sales $10.2B (+2%); Q4 comparable EPS $2.63 (+14%).
Constellation Q3 comparable EPS $3.25 flat YoY; cuts FY2025 outlook, raises cash flow
Q3 net sales $2.464B (flat YoY); reported diluted EPS $3.39 (+23%); comparable EPS $3.25 (flat).
Constellation Brands signs agreement to sell SVEDKA vodka to Sazerac
SVEDKA brand divested to Sazerac; deal expected to close in coming months subject to regulatory approvals.
Constellation Brands Q2 FY2025: comparable EPS $4.32, +14%; Beer sales up mid-single digit
Net sales $2,919M (+3% comparable); comparable operating income $1,090M (+13%).
Constellation Brands updates FY2025 outlook, expects $1.5B-$2.5B Wine & Spirits goodwill impairment
Updated FY2025 comparable EPS guidance $13.60-$13.80, raised lower end; reported EPS $3.05-$7.92 includes impairment.
Constellation Brands Q1 FY25 revenue +6% to $2.66B; comparable EPS +17% to $3.57
Net sales $2,662M (+6% YoY); comparable diluted EPS $3.57 (+17%).
Greenstar and CBG converted 17,149,925 Canopy common shares (18.8% stake) into non-voting exchangeable shares.
Constellation Brands beats FY 2024 EPS outlook; beer business outperforms; issues FY 2025 guidance
FY 2024 comparable EPS excl. Canopy EIE $12.38, up 9% YoY; net sales $9.96B (+5%).
On that date, the Board filled the additional Board seat by electing E. Morgan Flatley to serve as a member of the Board effective immediately.
On August 29, 2024, the Board of Directors of Constellation Brands, Inc. (the “Company”) accepted the resignation of Judy A. Schmeling as a member of its Board of Directors, effective immediately.
Max materiality 0.90 · Median 0.50 · Most common event debt